FDA Roundup: February 6, 2024
SILVER SPRING, Md., Feb. 6, 2024 /PRNewswire/ — Today, the U.S. Food and Drug Administration is providing an at-a-glance summary of news from around the agency: On Monday, the FDA issued an outbreak advisory warning consumers not to eat, sell, or serve recalled brands of cheeses, sour cream
WHAT’S NEW AT GRANDE LAKES ORLANDO IN 2024
The award-winning resort will offer innovative partnerships, unique programming, and world-class amenities in the year ahead ORLANDO, Fla., Feb. 6, 2024 /PRNewswire/ — Grande Lakes Orlando, the 500-acre luxury Florida resort in the headwaters of the Florida Everglades anchored by The Ritz-Carl
Monotype Acquires an Award-Winning Type Collection from Sharp Type’s Library and Welcomes Sharp Type as a Creative Partner
Monotype to acquire an award-winning type collection from Sharp Type foundry. US-based foundry Sharp Type will join the Monotype Creative Partner Program, working alongside other independent foundries and Monotype on creative custom design work. WOBURN, Mass., Feb. 6, 2024 /PRNewswire/ — Tod
CAQH Announces an Initiative with Leading Health Plans to Support Healthcare Providers and Improve Data Quality
The effort, outlined in a new issue brief, “Improving Provider Data Quality: A Collaborative Initiative,” focuses on ways collective action can address complex, costly problems related to payer-provider data-sharing that impacts the healthcare experience for all. WASHINGTON, Feb. 6, 20
GRYPHON INVESTORS TO SELL HEPACO TO CLEAN HARBORS FOR $400 MILLION
SAN FRANCISCO, Feb. 6, 2024 /PRNewswire/ — Gryphon Investors (“Gryphon”), a leading middle-market private equity firm, announced today that it has signed an agreement to sell HEPACO, LLC (“HEPACO” or “the Company”) to Clean Harbors Inc. (“Clean Harbor
ROSEN, A LEADING AND RANKED FIRM, Encourages Golden Heaven Group Holdings Ltd. Investors to Secure Counsel Before Important February 20 Deadline in Securities Class Action First Filed by the Firm – GDHG
NEW YORK, Feb. 6, 2024 /PRNewswire/ — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of the securities of Golden Heaven Group Holdings Ltd. (NASDAQ: GDHG) between April 13, 2023 and December 8, 2023, both dates inclusive (the “Class Period”), of the imp
The Brattle Group Announces 10 New Promotions to Principal
BOSTON, Feb. 6, 2024 /PRNewswire/ — The Brattle Group is pleased to share that 10 experts were recently promoted to Principal: Dr. Can Çeliktemur, Dr. Charlie Gibbons, Dr. Lucrezio Figurelli, Dr. Yingzhen Li, Mame Maloney, Dr. Nguyet Nguyen, Ilinca Popescu, Dr. Shastri Sandy, Chris Wall, a
Chef Kevin Quinn Honored as a Recipient of Career Education Review’s Exceptional Educator Awards
CHICAGO, Feb. 6, 2024 /PRNewswire/ — Career Education Review (CER) recently named Kevin Quinn, Auguste Escoffier School of Culinary Arts chef instructor as a recipient of its Exceptional Educator Awards. The Award recognizes outstanding career college faculty, administrators, and leaders who h
Pye-Barker Fire & Safety Celebrates NASCAR Partnership and Invites Career Seekers to Define Their Legacy
ATLANTA, Feb. 6, 2024 /PRNewswire/ — Pye-Barker Fire & Safety – the largest fully integrated and full-service fire protection, life safety and security services provider in the United States – is proud to continue its support of NASCAR driver John Hunter Nemechek for the 2024 season.
Europe Constrained Peptide Drugs Market Analysis and Forecast Report 2024-2040 Featuring Bicycle Therapeutics, Spexis, Santhera Pharmaceuticals, Union Chimique Belge, Biosynth, and Zealand Pharma
DUBLIN, Feb. 6, 2024 /PRNewswire/ — The “Europe Constrained Peptide Drugs Market: Analysis and Forecast, 2024-2040” report has been added to ResearchAndMarkets.com’s offering. The market size is anticipated to be $0.06 billion in 2026 and is expected to reach $7.72 billion
